Kyn Therapeutics

Kyn Therapeutics

Kyn Therapeutics

Kyn Therapeutics is a biotechnology company advancing new immunometabolic therapies for cancer.
Founded
2016
Raised
$49M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$49,000,000
Venture capital (Series A) - 2017
Atlas Venture OrbiMed
Team Size
2
Employees

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Kyn Therapeutics makes some noise.